Most Important Terms & Conditions (MITC)

RA shall also disclose Most Important Terms and Conditions (MITC) as specified below to their clients. These terms and conditions have been standardized by the Industry Standards Forum (ISF) in consultation with SEBI and RAASB.

• These terms and conditions, and consent thereon, are for the research services provided by the Research Analyst (RA).
• The RA cannot execute or carry out any trade (purchase/sell transaction) on behalf of the client.
• Clients are advised not to permit the RA to execute any trade on their behalf.

• The fee charged by the RA to the client will be subject to the maximum amount prescribed by SEBI / Research Analyst Administration and Supervisory Body (RAASB) from time to time. This is applicable only for Individual and HUF Clients.
• a. Current Fee Limit: The current fee limit is Rs 1,51,000/- per annum per family of client for all research services of the RA.
• b. Statutory Charges: The fee limit does not include statutory charges.
• c. Non-Individual / Accredited Investors: The fee limits do not apply to a non-individual client / accredited investor.

• RA may charge fees in advance if agreed by the client.
• Such advance shall not exceed the period stipulated by SEBI; presently it is one quarter.
• In case of premature termination of the RA services by either the client or the RA, the client shall be entitled to seek refund of proportionate fees only for the unexpired period.

• Fees to the RA may be paid by the client through any of the specified modes such as cheque, online bank transfer, UPI, etc.
• Cash payment is not allowed.
• Optionally, the client can make payments through Centralized Fee Collection Mechanism (CeFCoM) managed by BSE Limited, which is currently recognized as RAASB.

The RA is required to abide by the applicable regulations, circulars and directions specified by SEBI and RAASB from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest.

The RA will endeavor to promptly inform the client of any conflict of interest that may affect the services being rendered to the client.

• Any assured, guaranteed or fixed return schemes or any other schemes of similar nature are prohibited by law.
• No scheme of this nature shall be offered to the client by the RA.

• The RA cannot guarantee returns, profits, accuracy, or risk-free investments from the use of the RA's research services.
• All opinions, projections and estimates of the RA are based on the analysis of available data under certain assumptions as of the date of preparation or publication of the research report.

• Any investment made based on recommendations in research reports is subject to market risks.
• Recommendations do not provide any assurance of returns.
• There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report.
• Any reliance placed on the research report provided by the RA shall be as per the client's own judgement and assessment of the conclusions contained in the research report.

The SEBI registration, enlistment with RAASB, and NISM certification do not guarantee the performance of the RA or assure any returns to the client.

For any grievances, clients may follow the steps below:

The client should first contact the RA using the details on its website or the following contact details:

• Customer Support Head / CEO: NACHIKET PRADIPRAO KHASALE
• Phone: +91 96996 63149
• Email: nachiketkhasale.insights88@gmail.com

If the resolution is unsatisfactory, the client can also lodge grievances through SEBI's SCORES platform at:

https://scores.sebi.gov.in/

The client may also consider the Online Dispute Resolution (ODR) through the Smart ODR portal:

https://smartodr.in/

Clients are required to keep contact details, including email ID and mobile number/s, updated with the RA at all times.

The RA shall never ask for the client's login credentials and OTPs for the client's Trading Account, Demat Account and Bank Account.

Never share such information with anyone, including the RA.